Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prostate Cancer Biomarker Enrichment and Treatment Selection (PC-BETS) Study

NCT03385655 is registered in ClinicalTrials.gov with Canadian Cancer Trials Group as lead sponsor.

NCT NCT03385655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03385655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prostate Cancer Biomarker Enrichment and Treatment Selection (PC-BETS) Study
Lead sponsor
Canadian Cancer Trials Group
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 1, 2018
Completion date
December 31, 2025
Enrollment
200 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer